tlooto
Sign up
Medicine

Immortal Time Bias Compromises Conclusions Regarding SGLT2 Inhibitor Use in Diabetic Prostate Cancer Patients on Hormone Therapy.

Kuo-Wang Tsai, Joshua Wang

2026.2.19CARDIOVASCULAR DRUGS AND THERAPY

DOI: 10.1007/s10557-026-07853-y

Abstract

Abstract is not available.

Citation format

TSAI, Kuo-Wang; WANG, Joshua. Immortal time bias compromises conclusions regarding SGLT2 inhibitor use in diabetic prostate cancer patients on hormone therapy. CARDIOVASCULAR DRUGS AND THERAPY, 2026.